IE45082L - Derivatives of pyrimidone and thiopyrimidone - Google Patents

Derivatives of pyrimidone and thiopyrimidone

Info

Publication number
IE45082L
IE45082L IE762814A IE281476A IE45082L IE 45082 L IE45082 L IE 45082L IE 762814 A IE762814 A IE 762814A IE 281476 A IE281476 A IE 281476A IE 45082 L IE45082 L IE 45082L
Authority
IE
Ireland
Prior art keywords
ring
optionally substituted
sulphur
bromine
lower alkyl
Prior art date
Application number
IE762814A
Other versions
IE45082B1 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of IE45082L publication Critical patent/IE45082L/en
Publication of IE45082B1 publication Critical patent/IE45082B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

There is disclosed the preparation of compounds of the formula FORMULA 1 wherein Het is a 2- or 4-imidazolyl ring optionally substituted by lower alkyl (preferably methyl), halogen(preferably chlorine or bromine), trifluoromethyl or hydroxymethyl, a 2-pyridyl ring optionally substituted by lower alkyl (preferably methyl), lower alkoxy (preferably. methoxy), halogen (preferably chlorine or bromine), amino or hydroxy, a 2-thiazolyl ring, a 3-isothiazolyl ring optionally substituted by chlorine or bromine, a 3-(1,2,5)-thiadiazolyl ring optionally substituted by chlorine or bromine, or a 2-(5-amino-1,3,4-thiadiazolyl) ring; Y is sulphur or a methylene group; Z is hydrogen or lower alkyl(preferably methyl); X is oxygen or sulphur; W is methylene, oxygen or sulphur: p and q are such that their sum is from 1 to 4 when W is oxygen or sulphur, or from 0 to 4 when W is methylene; Het' is a 5 or 6 membered heterocycle such as pyridine, furan,thiophen, thiazole, oxazole, isothiazole, imidazole, pyrimidine, pyrazine or pyridazine,which ring is optionally substituted by lower alkyl, lower alkoxy, or may have a benzene ring or substituted benzene ring fused to it. The compounds have been found to be histamine H2- antagonists and are useful as inhibitors of gastric acid secrection, as antiinflammatory agents and as agents which act on the cardiovascular system. [CA1073458A]
IE2814/76A 1975-12-29 1976-12-22 Derivatives of pyrimidone and thiopyrimidone IE45082B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (2)

Publication Number Publication Date
IE45082L true IE45082L (en) 1977-06-29
IE45082B1 IE45082B1 (en) 1982-06-16

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2814/76A IE45082B1 (en) 1975-12-29 1976-12-22 Derivatives of pyrimidone and thiopyrimidone

Country Status (37)

Country Link
JP (1) JPS5283388A (en)
AR (1) AR222290A1 (en)
AT (1) AT360024B (en)
AU (1) AU508123B2 (en)
BE (1) BE849810A (en)
BG (1) BG29722A3 (en)
CA (1) CA1073458A (en)
CH (1) CH631981A5 (en)
CS (1) CS203995B2 (en)
DD (1) DD128588A5 (en)
DE (1) DE2658267A1 (en)
DK (1) DK587076A (en)
EG (1) EG12439A (en)
ES (1) ES454656A1 (en)
FI (1) FI62668C (en)
FR (1) FR2336935A1 (en)
GR (1) GR62441B (en)
HU (1) HU175171B (en)
IE (1) IE45082B1 (en)
IL (1) IL51040A (en)
IT (2) IT1124740B (en)
LU (1) LU76481A1 (en)
MW (1) MW5076A1 (en)
MX (1) MX5119E (en)
NL (1) NL7614538A (en)
NO (1) NO146396C (en)
NZ (1) NZ182759A (en)
OA (1) OA05526A (en)
PH (1) PH14723A (en)
PL (1) PL104376B1 (en)
PT (1) PT65949B (en)
RO (1) RO72475A (en)
SE (1) SE431544B (en)
SU (1) SU791235A3 (en)
YU (1) YU311676A (en)
ZA (1) ZA767198B (en)
ZM (1) ZM14376A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
IN151188B (en) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
DE2962542D1 (en) * 1979-04-11 1982-06-03 Smith Kline French Lab Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (en) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
DK587076A (en) 1977-06-30
PH14723A (en) 1981-11-13
SE431544B (en) 1984-02-13
NL7614538A (en) 1977-07-01
DD128588A5 (en) 1977-11-30
CH631981A5 (en) 1982-09-15
NO764370L (en) 1977-06-30
RO72475A (en) 1982-10-26
DE2658267A1 (en) 1977-07-07
ZA767198B (en) 1977-11-30
NO146396C (en) 1982-09-22
EG12439A (en) 1979-09-30
ES454656A1 (en) 1977-11-16
NZ182759A (en) 1978-06-02
SE7614620L (en) 1977-06-30
CS203995B2 (en) 1981-03-31
AT360024B (en) 1980-12-10
AU2097676A (en) 1978-07-06
OA05526A (en) 1981-04-30
PT65949A (en) 1977-01-01
ATA960876A (en) 1980-05-15
HU175171B (en) 1980-05-28
IL51040A0 (en) 1977-02-28
BE849810A (en) 1977-06-23
GR62441B (en) 1979-04-12
IT1124740B (en) 1986-05-14
PT65949B (en) 1978-06-15
IL51040A (en) 1980-12-31
YU311676A (en) 1983-01-21
BG29722A3 (en) 1981-01-15
ZM14376A1 (en) 1977-08-22
IE45082B1 (en) 1982-06-16
CA1073458A (en) 1980-03-11
JPS5283388A (en) 1977-07-12
FR2336935A1 (en) 1977-07-29
JPS6129355B2 (en) 1986-07-05
FI62668C (en) 1983-02-10
FR2336935B1 (en) 1980-03-21
IT7919107A0 (en) 1979-01-05
LU76481A1 (en) 1977-06-15
FI763664A (en) 1977-06-30
AR222290A1 (en) 1981-05-15
SU791235A3 (en) 1980-12-23
NO146396B (en) 1982-06-14
FI62668B (en) 1982-10-29
PL104376B1 (en) 1979-08-31
MX5119E (en) 1983-03-24
AU508123B2 (en) 1980-03-13
MW5076A1 (en) 1978-02-08

Similar Documents

Publication Publication Date Title
IE45082L (en) Derivatives of pyrimidone and thiopyrimidone
US7524870B2 (en) Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
IE47211B1 (en) 7-( -oximino- -(2-aminothiazol-4-yl)acetamido)cephalosporanic acid derivatives
DK276985A (en) BENZOFURAND DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A RELATIONSHIP
JPS6052756B2 (en) Cefem derivatives and their production method
IE790785L (en) Benzimidazole derivatives
US4201779A (en) 7[(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives and processes for their preparation
NO178067B (en) Analogous process for the preparation of therapeutically active heterocyclic compounds
EP0068833B1 (en) Pyrimidinone derivatives and pharmaceutical compositions containing them
KR890004664B1 (en) 2-(2-pyridyl)methyl suefinyl thieno imidazols and related compounds
JO1164B1 (en) A process for preparing certain pyrimidone derivatives useful as histamine h2- antagonists
SE8300580L (en) SUBSTITUTED 1,3,4-THIADIAZOLO (3,2-A) PYRIMIDINES AND PROCEDURES FOR THEIR PREPARATION
NO743992L (en)
GB1464033A (en) Process for preparing quinazolinones
GB1582528A (en) Amino pyrimidone derivatives
KR860002184B1 (en) Process for preparing cephem derivatives
JPS5283887A (en) Heterocyclic compounds
JPS5748983A (en) Thiazoldine derivative
JPS52106895A (en) 77*nnacylaminooaaaryl orrthienylacetamido**33*heterocyclic thiomethyl* 33cephemm44carboxylic acids
KR830000733B1 (en) Method for preparing cephem derivatives
JPS5227798A (en) Process for preparing heterocyclic compounds
JPS5371080A (en) Novel benzimidazole cpds. and process for preparing them
JPS5283886A (en) Hetero cyclic compounds
JPS535191A (en) Preparation of n-acylamino-alpha-arylacetamido cephalosporins
NO792231L (en) PROCEDURE FOR MANUFACTURING CEPHEM RELATIONS